Drug Information for Diabetes Mellitus Outpatients at RSUD X Surabaya: What was Provided and what was Known?

  • Shieny Agustin Santoso Faculty of Pharmacy, University of Surabaya
  • Adji Prayitno Setiadi Center for Medicines Information and Pharmaceutical Care (CMIPC), Faculty of Pharmacy, University of Surabaya
  • Karina Kumaladewi Widjaja Center for Medicines Information and Pharmaceutical Care (CMIPC), Faculty of Pharmacy, University of Surabaya
  • Yosi Irawati Wibowo Center for Medicines Information and Pharmaceutical Care (CMIPC), Faculty of Pharmacy, University of Surabaya

Abstract

The prevalence of Diabetes Mellitus (DM) in Indonesia has increased 0.5% in the last five years. This study aimed to evaluate information provided and level of knowledge among DM patients on their treatment at the outpatient clinic at the X Public Hospital (Rumah Sakit Umum Daerah, RSUD), Surabaya, Indonesia. This was a cross-sectional study using a checklist developed by The Food And Drug Supervisory Agency which consists of 11 types of information. The data were analysed descriptively; to test the relationship between the amount of information provided and the patient's level of knowledge, Spearman correlation analysis was used. A total of 110 patients were included in this study (response rate 90.91%). The mean of information provided and understood by patients was 6.48/11±0.73 and 7.48/11±0.90, respectively. There was a significant relationship between information provided to and known by patients (p=0.001). Characteristic factors such as age (p=0.001), education level (p=0.001), and sources of information related to DM (p=0.014) were shown to influence DM patients' knowledge of their treatment. This study indicated the importance of providing clear and complete drug information, especially for patients on long-term therapy, to improve their knowledge, thus potentially increasing adherence and optimizing therapy outcomes.

References

1. American Diabetes Association. Standards of Medical Care in Diabetes. American Diabetes Association Inc. 2020;43(1):1–212.

2. World Health Association. Diabetes Fact Sheet [Internet]. WHO. 2016. [cited 15 November 2017]. Available from: https://www.euro.who.int/__data/assets/pdf_file/0010/305389/Diabetes-Fact-Sheet-en.pdf

3. International Diabetes Federation. IDF Diabetes Atlas Edisi ke-7. Belgium: International Diabetes Federation Inc; 2015.

4. Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar (RISKESDAS) 2013. Lap. Nas. 2013;1–384.

5. Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar (RISKESDAS) 2018. Lap. Nas. 2018;1–674.

6. Edwina DA, Manaf A, Efrida. Pola Komplikasi Kronis Penderita Diabetes Melitus Tipe 2 Rawat Inap di Bagian Penyakit Dalam RS Dr. M. Djamil Padang Januari 2011-Desember 2012. Jurnal Kesehatan Andalas. 2015;4(1):102-106. https://doi.org/10.25077/jka.v4i1.207

7. Haryono R, Effendy C, Aulawi K. Gambaran Pelaksanaan Discharge Planning Pada Pasien Diabetes Mellitus
[Internet]. JIK. 2008 [cited 29 January 2021]. Available from: https://jurnal.ugm.ac.id/jik/article/view/10294/7777

8. Notoatmodjo S. Promosi Kesehatan dan Ilmu Perilaku. Jakarta: PT Rineka Cipta; 2007.

9. Sari EM. Pengaruh Pemberian Informasi Obat Antihipertensi Terhadap Tingkat Pengetahuan Pasien Tentang
Obat Antihipertensi [Internet]. Akademi Farmasi Putra Malang. 2018 [cited 30 December 2020]. Available from: http://repository.pimedu.ac.id/id/eprint/332/1/ARTIKEL%20ILMIAH%20ELLA%20MONICA_15039.pdf

10. Kerzman H, Baron-Epel, Toren. What do Discharge Patient Know About Their Medication? Patient Education and Counseling. Philadhelpia. 2005;56(3):276-282. https://doi.org/10.1016/j.pec.2004.02.019

11. Azwar A, Joedo P. Metodologi Penelitian Kedokteran dan Kesehatan Masyarakat. Jakarta: Binapura Aksara; 2014.

12. Badan Pengawas Obat dan Makanan. Kriteria dan Tatalaksana Registrasi Obat. BPOM. 2017:1-259.

13. Cohen J. A Coefficient of Aggrement for Nominal Scales. Educ Psychol Meas. 1960;20:37-46. https://doi.org/10.1177/001316446002000104

14. Rantucci MJ. Komunikasi Apoteker-Pasien: Panduan Konseling Pasien Edisi ke-2. Jakarta: Buku Kedokteran EGC; 2007.

15. Gaurav T, Ruchi T, Birendra S. Drug Delivery Systems: An Updated Review. Int J Pharm Investig. 2012;2(1):2-11. https://doi.org/10.4103/2230-973X.96920

16. Kementrian Kesehatan RI. Modul Penggunaan Obat Rasional. Jakarta; 2011.

17. Departemen Kesehatan RI. Pharmaceutical Care Untuk Penyakit Diabetes Mellitus. Jakarta; 2005.

18. Hayati N. Cara Menyimpan Obat dan Jangka Waktu Penyimpanan Obat. Jakarta: Informasi Perlindungan Kesehatan; 2016.

19. Hartayu TS, Widayati A, Wijoyo Y. Peningkatan Pelayanan Informasi Obat bagi Pasien Diabetes Melitus. Jurnal Farmasi Klinik Indonesia. 2013;2(3):102-111. https://doi.org/10.15416/ijcp

20. Suryandari L. Analisis Kualitas Informasi Obat Untuk Pasien di Apotek Kota Surakarta [Skripsi]. Surakarta: Universitas Muhammadiyah; 2015.

21. Ganong WF. Fisiologi Kedokteran Edisi ke-22. Jakarta: EGC; 2008.

22. Gultom YT. Tingkat Pengetahuan Pasien Diabetes Mellitus Tentang Manajemen Diabetes Mellitus di Rumah Sakit Pusat Angkatan Darat Gatot Soebroto Jakarta Pusat [Undergraduate Thesis]. Jakarta: Universitas Indonesia; 2012.

23. Octaviani P. Pengaruh Pemberian Konseling Farmasis dengan Alat Bantu Terhadap Kepatuhan Pasien Diabetes Melitus Tipe 2 Anggota Prolanis di Puskesmas Purwokerto Utara. Viva Medika. 2017;10(1):68-78. https://doi.org/10.35960/VM.V10I2.370

24. Srikartika VM, Akbar MR, Lingga HN. Evaluasi Intervensi Media Booklet Terhadap Tingkat Pengetahuan dan
Kepatuhan Pasien Diabetes Melitus Tipe 2 di Puskesmas Banjarbaru Selatan. Jurnal Publikasi Kesehatan Masyarakat Indonesia. 2019;6(1):27-35. https://doi.org/10.20527/jpkmi.v6i1.6874

25. Dini A. Gambaran Pengetahuan Penderita Tuberkulosis Paru Tentang Penyakit dan Pengobatan Tuberkulosis di RSUP Adam Malik Medan [Undergraduate Thesis]. Medan: Universitas Sumatera Utara; 2010.

26. Irawan E. Faktor-Faktor Yang Berhubungan Dengan Pengetahuan Masyarakat Tentang Diabetes Mellitus Tipe 2 [Internet]. Jurnal Keperawatan BSI. 2018 [cited 29 January 2021]. Available from: https://ejournal.bsi.ac.id/ejurnal/index.php/jk/article/view/4316

27. Notoatmodjo S. Promosi Kesehatan. Jakarta: Salemba Medika; 2010.

28. Nurcahya D. Hubungan Pengetahuan Mengenai Diabetes Melitus Dengan Kualitas Hidup Penderita Diabetes Melitus Tipe 2 di RSUP Haji Adam Malik Medan [Undergraduate Thesis]. Medan: Universitas Sumatera Utara; 2017.
Published
2023-04-28
How to Cite
SANTOSO, Shieny Agustin et al. Drug Information for Diabetes Mellitus Outpatients at RSUD X Surabaya: What was Provided and what was Known?. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 21, n. 1, p. 27-33, apr. 2023. ISSN 2614-6495. Available at: <http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/1104>. Date accessed: 10 june 2023. doi: https://doi.org/10.35814/jifi.v21i1.1104.
Section
Articles